Dropping your shorts

Most recent short interest data argue against imminent bubble in biotech

While some investors have begun to wonder out loud if there is a biotech bubble forming, the short interest numbers suggest the answer is "not yet" - although short interest in the larger biotechs is up over the past year.

Short interest for the iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) ticked up 5% between Dec. 31 and Jan.

Read the full 591 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE